Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

John Dimar

Orthopaedic Surgery of the Spine Louisville, KY Medical Doctor

NPI 1235192451 CMS profile 328396

210 E Gray St, Suite 900, Louisville, KY 40202

Open in the dashboard

General payments

$265,942

320 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, John Dimar of Louisville, KY is reported in the CMS Open Payments database as having received $265,942 across 320 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 86th percentile of Orthopaedic Surgery of the Spine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $21,290 40
2024 General $18,884 51
2023 General $41,593 52
2022 General $28,449 30
2021 General $64,694 63
2020 General $17,094 15
2019 General $73,936 69

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • John Dimar
  • Orthopaedic Surgery of the Spine median
  • Middle half of Orthopaedic Surgery of the Spine
  • National median

In program year 2025, general payments to John Dimar were reported at $21,290. Among 1,704 Orthopaedic Surgery of the Spine profiles paid that year, the median was $2,061 and the middle half received between $347 and $14,651.

Show as a table
Year John Dimar Orthopaedic Surgery of the Spine median Middle half National median
2019 $73,936 $2,106 $337–$18,608 $163
2020 $17,094 $1,213 $156–$15,082 $114
2021 $64,694 $1,834 $271–$15,617 $132
2022 $28,449 $2,015 $320–$17,036 $149
2023 $41,593 $1,925 $336–$14,599 $160
2024 $18,884 $2,110 $341–$12,483 $164
2025 $21,290 $2,061 $347–$14,651 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Stryker Corporation $104,966 131 payments
  2. Medical Device Business Services, Inc. $57,958 35 payments
  3. Medtronic USA, Inc. $38,986 31 payments
  4. Medtronic, Inc. $34,378 58 payments
  5. icotec Medical Inc. $19,169 36 payments
  6. VB Spine LLC $8,074 7 payments
  7. Globus Medical, Inc. $1,033 10 payments
  8. Amgen Inc. $986 8 payments
  9. NuVasive, Inc. $174 1 payment
  10. Radius Health, Inc. $123 1 payment
  11. Other $95 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $202,092 57 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $33,600 6 payments
  3. Travel and Lodging $20,055 97 payments
  4. Food and Beverage $10,195 160 payments
Products named General payments · program years 2019–2025
  1. EVEREST SPINAL SYSTEM $43,960 16 payments
  2. CONDUIT $30,251 9 payments
  3. CD HORIZON $27,510 20 payments
  4. EXPEDIUM $24,540 12 payments
  5. XIA 3 $15,600 1 payment
  6. OASYS $15,600 1 payment
  7. icotec BlackArmor Spine System $15,260 20 payments
  8. GENERAL K2M PRODUCT DISCUSSION $14,788 5 payments
  9. CD HORIZON SPINAL SYSTEM $12,664 17 payments
  10. DIVERGENCE-L $10,792 9 payments
  11. Other $100,389 164 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 46 billing codes

Paid by Medicare

$103,056

Medicare's payments for the services billed

Medicare patients

131

Average age 73

Services billed

509

64 women, 67 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 37%
Depression 34%
Ischemic heart disease 31%
Osteoporosis 31%
COPD 29%
Chronic kidney disease 28%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

2 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
EVENITY
  • Amgen Inc. $195
$195 — —
Prolia
  • Amgen Inc. $75
$75 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

320 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery of the Spine in Kentucky

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record